Persistence in muscle of an adenoviral vector that lacks all viral genes. - Wikidata - wikimedia - TriplyDB

Persistence in muscle of an adenoviral vector that lacks all viral genes.

Persistence in muscle of an adenoviral vector that lacks all viral genes.

http://www.wikidata.org/entity/Q36018705

about

Gutless adenovirus: last-generation adenovirus for gene therapy Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.In vivo acceleration of heart relaxation performance by parvalbumin gene delivery Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.Engineering viral vectors to subvert the airway defense response.Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders Improvements in adenoviral vector technology: overcoming barriers for gene therapy.Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells Gene therapy: development of immunostimulatory treatments for cancer.Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin.Novel approaches to treat muscular dystrophies.The promise and potential hazards of adenovirus gene therapy.Gene therapy for haemophilia.Optimization of the helper-dependent adenovirus system for production and potency in vivo.Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer.Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for ch Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.Gene transfer techniques for cardiac arrhythmias.Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances Methods for gene transfer to the central nervous system.An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus Adenoviral vectors: development and application.Helper-dependent adenoviral vectors in experimental gene therapy.Modification of cellular communication by gene transfer.Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.The role of heparan sulfate and perlecan in bone-regenerative procedures.Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons Gene therapy for cardiac arrhythmias: a dream soon to come true?Emerging strategies for cell and gene therapy of the muscular dystrophies Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.Lasting reduction of cocaine action in neostriatum--a hydrolase gene therapy approach Designing heart performance by gene transfer.

P2860

Q28277560-995C040D-A810-413C-8C6E-C20821EE723E Q30395754-A9633871-F5D1-410A-BC60-07292C3550C9 Q30501538-20D27CC7-B615-43CC-AF86-3EB5499CFAA7 Q33424498-39A6DB52-8A64-45DB-BB71-79C2BA70ACD6 Q33603763-D584A998-1E67-4082-B4DF-5B96DC78C47F Q33643006-703A5EFE-CDF9-473F-BBD2-070B0B4C2A66 Q33651199-84B40A2A-33C1-4400-9C9A-B6FC942333C2 Q33783991-13649BA8-83EB-4AD0-8271-57250B9EEE44 Q33817535-AEF5C5B1-0F73-4FCB-AAA1-2212DABBC073 Q33818929-3A322F15-AA6F-4BFB-ADA7-942CE4473E99 Q33849814-D512E243-CCCD-4EF6-BD41-05D5A034A232 Q33985663-EA72E477-B60F-4897-AB7E-889DBFF779D7 Q34005922-6A90C573-48E3-4A81-98E2-EC3194690653 Q34035676-3D88DCF4-285D-49AE-BC78-6050E3CEEEEF Q34187915-F8A4D243-809C-400E-B2FD-DAD248EFA5D8 Q34190967-4317A0D9-9B9B-475D-B6BC-FB8A9CA80A1E Q34204364-9AF467DE-5BBD-4B6C-B2D2-AF1257C3C3CD Q34219407-13B8E79A-DBEE-4DF1-8164-997FC61FEF4C Q34530130-2CB06BEE-0674-4B30-A0C8-7515BC15FB77 Q34996749-E7363084-4993-4B9A-A02A-8648F11B5B06 Q34999908-1E66735E-9C56-472B-BF35-5EEA840431C0 Q35086122-BA74F46D-813C-43B8-A966-F2BD016E25AD Q35131227-2B113305-00BB-4875-9B66-AF22383ED857 Q35161530-3FEE9C7D-E468-45BE-9197-A1D88F6BDF90 Q35568410-A01759D1-E2FF-4556-801C-FA5912B483E3 Q35791493-ACB1A065-C54F-482B-87D1-AD33C8A99064 Q35847178-B8A86D5F-7705-4211-BCEC-1A46B5392ABB Q35902332-1E13FA23-CE2E-4728-906C-762146A975DE Q35924750-933FE257-5D7B-4456-82E9-37F3B7579F51 Q36179657-C6B224D6-BD6A-4FB9-9CBA-C616602479BE Q36219334-5DC0530A-63A9-48DE-959E-1675C5C91225 Q36225135-694E43AE-74DB-4DD6-8D70-5C6C8BE35619 Q36310768-76C27855-552C-4B1C-A242-8FB8FBA8560D Q36376753-580AD870-85DB-4FAD-A9FC-21B9106D51AF Q36557727-9A22D945-D4E1-4A39-B32C-701303FE3C17 Q36800517-E6523F7E-6DDC-4F46-BFF2-BAA96B3BC0A3 Q36960845-C09D8826-2842-4A55-959D-6BC29B60EE6F Q36981370-8312F050-CDE4-4CF0-8A45-E157F4B457BC Q37267978-50C4FADE-650A-440B-860A-C1A17F9E2520 Q37299072-26E3D1CF-BC6D-42EE-92AC-FA005286B849

P2860

Persistence in muscle of an adenoviral vector that lacks all viral genes.

http://www.wikidata.org/entity/Q36018705

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Persistence in muscle of an adenoviral vector that lacks all viral genes.

@ast

Persistence in muscle of an adenoviral vector that lacks all viral genes.

@en

type

label

Persistence in muscle of an adenoviral vector that lacks all viral genes.

@ast

Persistence in muscle of an adenoviral vector that lacks all viral genes.

@en

prefLabel

Persistence in muscle of an adenoviral vector that lacks all viral genes.

@ast

Persistence in muscle of an adenoviral vector that lacks all viral genes.

@en

P1433

Q36018705-7C227928-730A-49B7-AB78-98A0923D47C9

P1476

Q36018705-B05BA490-40D4-4134-BD5B-515DD4FA02BE

P2093

Q36018705-064BF204-EF8B-48BB-8567-1390F381DFB4

Q36018705-4FC467A9-1287-41F6-926B-F6D965997E62

Q36018705-5EA40F6A-8AA9-47AA-8F10-1E5985907416

Q36018705-6FB07CDD-7110-42F2-A46E-A5B4338B9CFC

Q36018705-86E7BF94-26A5-463F-8101-4A9B7A6C7815

Q36018705-FFB8CA35-9D3B-4355-A242-4D4AF8AAF7A4

P2860

Q36018705-01FC6240-49BB-49AB-87F8-2E5781D7BE34

Q36018705-13D7E878-9E8F-4BAA-B0C8-38C56BA63CA4

Q36018705-17AD944E-C3BC-4309-A005-D31F0D562462

Q36018705-1868C4B0-84F4-4F49-9168-0281CB75182B

Q36018705-25D7D90E-598D-4937-A500-77794A4EE3D9

Q36018705-2F5DE35E-9404-48A8-AA56-78D584EB4435

Q36018705-37271A57-D722-46D4-9396-17950B048F3F

Q36018705-373C1140-E6B4-4F96-BA8A-C9C0D6744459

Q36018705-4B33C7AD-9C2E-4245-B8D8-C3E9CF07A34F

Q36018705-600D9D7C-2A07-4050-9975-A4E30A4FB318

P304

Q36018705-F6C9EA24-7DE2-4F0C-87EA-4E6DBD86CD04

P31

Q36018705-6211EE78-7CBC-44A1-BD2B-33FB6E5C8E63

P356

Q36018705-7E46C2BF-5C44-408D-AAB3-A0937FB820A2

P407

Q36018705-3E38A880-7BB9-4E13-B1E3-3C9BCC065F2E

P433

Q36018705-88CD6708-4FF1-47E8-BDC5-1DAB83127F2E

P478

Q36018705-8F1456E7-964A-4AD5-8C76-4216C2FB42C0

P577

Q36018705-76C21C30-EB05-4355-9BC9-930A31E160AB

P5875

Q36018705-A25E21F3-0E09-4F46-9028-E7D804A95631

P698

Q36018705-4CAFEA9F-378F-4076-8F5E-9F9103864C3F

P921

Q36018705-49089B92-495C-4842-BBA2-9667CDB1AD6A

Q36018705-E6B0B352-5D53-4840-8072-3283C5A7CD69

P932

Q36018705-3B85BF5C-2A9A-43C8-B927-9DAA06E1DE69

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Persistence in muscle of an adenoviral vector that lacks all viral genes.

@en

P2093

H H Chen

http://www.w3.org/2001/XMLSchema#string

L M Mack

http://www.w3.org/2001/XMLSchema#string

M Ontell

http://www.w3.org/2001/XMLSchema#string

P R Clemens

http://www.w3.org/2001/XMLSchema#string

R Kelly

http://www.w3.org/2001/XMLSchema#string

S Kochanek

http://www.w3.org/2001/XMLSchema#string

P2860

The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.

Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice

Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants.

Adenovirus as an expression vector in muscle cells in vivo

Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts.

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

P304

1645-1650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.5.1645

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14160291

http://www.w3.org/2001/XMLSchema#string

P698

9050832

http://www.w3.org/2001/XMLSchema#string

P921

viral persistence

P932

19970

http://www.w3.org/2001/XMLSchema#string